From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Respiratory Infections>
  4. Archives

Respiratory Infections: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 276-300 of 733 are shown

Pneumococcal Vaccine Prevents Pneumonia in Nursing Homes

Mortality from pneumococcal pneumonia was lower in vaccinated residents.

2009 H1N1 Influenza and HIV Infection

HIV infection does not seem to increase the risk for or severity of 2009 H1N1 influenza, according to data presented at the 2010 Retrovirus Conference.

Do Probiotics Lower Incidence of Ventilator-Associated Pneumonia?

A recent meta-analysis suggests that they could, but doubt remains.

Pneumococcal Conjugate Vaccine: Not Just for Kids Anymore

A 7-valent pneumococcal conjugate vaccine proved efficacious in preventing invasive pneumococcal disease among HIV-infected adolescents and adults.

Lung Cancer After Pneumonia: Red Herring or Canary in a Coal Mine?

A substantial proportion of postpneumonia patients subsequently receive lung cancer diagnoses.

Maternal Flu and the Postnatal Brain: An Animal Study

In rhesus monkeys, titers of virus-specific immunoglobulin are associated with brain abnormalities.

Genome-Wide RNA Interference Reveals New Influenza Treatment Targets

Host factors might be excellent targets for stopping viral replication.

When to Start Antiretroviral Therapy in HIV-Infected Patients with Tuberculosis?

Trial results from South Africa demonstrate unequivocally that coinfected patients should start antiretroviral therapy no more than 4 weeks after completing the intensive phase of tuberculosis therapy. Whether earlier initiation leads to better outcomes remains to be determined.

A Better Approach for Tuberculosis Screening and Diagnosis

Almost all HIV-infected patients with TB have cough, fever, or night sweats; however, culture is required for diagnosis in most patients with these symptoms.

Doxycycline for Acute Exacerbations of Chronic Obstructive Pulmonary Disease?

In a small randomized trial, 30-day outcomes were no better with doxycycline than with placebo.

A Critical Look at Flu Vaccine Studies

The vaccine can give the impression of preventing death even when no influenza is in sight.

Vancomycin plus Rifampin for Nosocomial Methicillin-Resistant Staphylococcus aureus Pneumonia?

In a small, randomized, open-label study, patients fared better with a combination of vancomycin and rifampin than with vancomycin monotherapy.

Management of Cryptococcal Disease

A long-awaited and comprehensive update of the previous guidelines

Cryptococcus gattii in a Temperate Region

<$EMPH_O>C. gattii<$EMPH_C> has become established in British Columbia, Canada; infection usually originates in the lungs but can spread elsewhere — notably, to the CNS.

Drug-Resistant TB Among Gold Miners in South Africa

Among gold miners in South Africa (many of them HIV infected), TB drug resistance spread despite treatment adherence.

TB Recurrence: Reinfection or Relapse?

Recurrences after successful TB treatment are more common among HIV-positive than HIV-negative patients, and the reasons are different: About half the recurrences in HIV-positive patients represent reinfection rather than reactivation.

Isoniazid Prophylaxis in HIV-Infected Patients

HIV-infected patients who received isoniazid preventive therapy as part of a clinical trial in Botswana had low rates of incident tuberculosis and severe adverse events; adherence was quite high.

Three Studies Demonstrate the Safety and Efficacy of Pandemic H1N1 Flu Vaccine

Results are in from studies in the U.S., China, and Hungary.

Respiratory Infections in the Setting of HIV

Viral pathogens were identified in about 65% of HIV-infected patients seeking outpatient care for respiratory symptoms. Influenza viruses were most common, followed by hMPV.

Incidence and Case Fatality Rates of Novel 2009 Pandemic A/H1N1 Influenza in England

H1N1 influenza incidence was highest among children, but H1N1-associated mortality was highest among elders.

Human Metapneumovirus: Innocent Bystander or Important Pathogen?

Among young children with alveolar infiltrates, HMPV was second only to RSV as a viral pathogen.

Air Pollution and Pneumonia

Among older adults, long-term exposure to nitrogen dioxide and fine particulates was associated with hospitalization for community-acquired pneumonia.

Sporulation in Mycobacteria: Another Look

Researchers have challenged the results of a study indicating that mycobacteria can produce endospores.

Clinical Outcomes of H1N1 Influenza in California Women During Pregnancy and Postpartum

Risk for severe illness and death extended into the postpartum period.

A Single H1N1 Immunization for Children?

A randomized clinical trial showed that a single 15-µg dose was immunogenic for children aged 6 months or older.

Items 276-300 of 733 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.